FERMT2 and esophageal squamous cell carcinoma: Recent research showed that the first miRNA we predicted (hsa-mir-200b) suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2 [74].